EU says people vaccinated with AstraZeneca shots should be able to travel to U.S
Reuters
Published Sep 21, 2021 07:19AM ET
Updated Sep 21, 2021 08:27AM ET
BRUSSELS (Reuters) -The European Commission said on Tuesday it would make sense for the United States to allow travel by people vaccinated with the AstraZeneca (NASDAQ:AZN) COVID-19 shots, although existing U.S. guidance already authorises those travellers.
On Monday, the White House said it would lift restrictions from November that bar EU citizens, including those fully vaccinated, from traveling to the United States.
"We believe the AstraZeneca vaccine is safe," Eric Mamer, a spokesperson for the EU Commission, told a news conference.
"From our point of view, obviously it would make sense for people who have been vaccinated with AstraZeneca to be able to travel," the spokesperson added, noting that this, however, was a decision for the U.S. authorities.
A spokeswoman for the U.S. Centers for Disease Control and Prevention (CDC) said that it currently considers people to be fully vaccinated, and therefore able to travel by air to the U.S., if they have received any of the FDA-authorized vaccines or shots approved by the World Health Organization, which include AstraZeneca's.
The regulatory U.S. Food and Drug Administration has so far authorised for use the COVID-19 vaccines produced by Pfizer/BioNTech, Moderna (NASDAQ:MRNA) and Johnson & Johnson (NYSE:JNJ), but is still reviewing the AstraZeneca shot.
The WHO has authorised the AstraZeneca vaccine, including the version made in Europe. The shot is also approved for use in the 27 EU countries where about 70 million doses have been administered cumulatively, according to public data.
The EU has its own safe-travel list, from which the United States was recently removed after a spike in infections there.
Most EU countries do not accept foreign nationals vaccinated with shots which are not authorised at EU level.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.